STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 102 filers reported holding STOKE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $10,960 | +28.2% | 1,031 | +0.5% | 0.00% | – |
Q1 2023 | $8,547 | +63.0% | 1,026 | +80.6% | 0.00% | – |
Q4 2022 | $5,243 | +162.2% | 568 | +385.5% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 117 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -83.3% | 117 | -79.2% | 0.00% | – |
Q1 2022 | $12,000 | +1100.0% | 562 | +1603.0% | 0.00% | – |
Q3 2021 | $1,000 | – | 33 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |